About Mark

Mark P. Wade holds the position of Global Practice Leader at TransPerfect Life Sciences, the largest Language translation company globally, where he is the resident SME for all clinical trial processes and translation. Mr. Wade’s 20 years in life sciences includes International Regional Director for EMEA at Ethicon and Ethicon Endo Surgery, Johnson & Johnson companies (NYSE: JNJ). For almost 10 years Mr. Wade was the Global Practice Leader at another global language translation company. He is a published expert in electronic clinical outcomes assessments (eCOA) including two ebooks, clinical posters and numerous articles in trade journals. He has significant experience and has published in clinical services, patient recruitment and site selection. 

Mr. Wade has chaired, presented and published posters at DIA Annual Symposia and numerous other internationally recognized conferences. He is an active committee member of C-Path eCOA Consortium, ISOQOL Translation & Cultural adaptation (TCA) Special Interest Group (SIG), ISPOR TCA SIG and DIA Endpoint Study Group.